ChIP-qPCR assays confirmed that silencing BRD4 or MED1 led to a decrease in the enrichment of BRD4 or MED1 on IGF2BP2-SE in HNSCC cells, respectively, resulting in the inhibition of IGF2BP2 transcriptional expression. The gene discussed is MED1; the disease is head and neck squamous cell carcinoma.